Clinical Trial Update: A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma [Phase 2]

View source ↗

Summary

Phase II trial evaluating vemurafenib combined with acitretin in advanced melanoma has been terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• Acitretin (Acitretin)
• Vemurafenib (vemurafenib)

Snippet

Sponsor: University of Arizona | Conditions: Malignant Melanoma | Phase 2 | Status: TERMINATED | Results posted: 2017-04-19